1. Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers
   Zhiwei Cui et al, 2022, Frontiers in Genetics CrossRef
2. An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients
   Linxin Liu et al, 2021, Aging CrossRef
3. Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients’ prognosis
   Xiaobin Wang et al, 2024, PeerJ CrossRef
4. ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway
   Sheng Chen et al, 2023, Urologia Internationalis CrossRef
5. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis
   Shucai Xie et al, 2019, PeerJ CrossRef
6. Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy
   Yu-Gui Zhang et al, 2021, Analytical Cellular Pathology CrossRef
7. Auricular fistula: a review of its clinical manifestations, genetics, and treatments
   Lamei Yuan et al, 2023, Journal of Molecular Medicine CrossRef
8. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity
   Xiaoyu Zhang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
9. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
   Lemeng Zhang et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
10. Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
    Yanju Lv et al, 2022, Frontiers in Genetics CrossRef
11. A two-gene-based prognostic signature for pancreatic cancer
    Shuyi Zhou et al, 2020, Aging CrossRef
12. A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma
    Xiaoxia Gong et al, 2022, Frontiers in Pharmacology CrossRef
13. ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma
    Feng Deng et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
14. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN
    Ziming Wang et al, 2021, BMC Cancer CrossRef
15. Anillin is an emerging regulator of tumorigenesis, acting as a cortical cytoskeletal scaffold and a nuclear modulator of cancer cell differentiation
    Nayden G. Naydenov et al, 2021, Cellular and Molecular Life Sciences CrossRef
16. Comprehensive multiomics and in silico approach uncovers prognostic, immunological, and therapeutic roles of ANLN in lung adenocarcinoma
    Prithvi Singh et al, 2023, Functional & Integrative Genomics CrossRef
17. Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
    Li-Ting Lai et al, 2023, Frontiers in Genetics CrossRef